AI assistant
Sending…
VOLITIONRX LTD — Director's Dealing 2013
Nov 18, 2013
34395_dirs_2013-11-18_f22deffe-6181-4946-9b78-59268dc54950.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2013-03-25
Reporting Person: Innes Guy Archibald (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-03-25 | Common Stock | P | 57292 | $114583.22 | Acquired | 926218 | Direct |
| 2013-11-14 | Common Sotck | P | 4878 | $7951.14 | Acquired | 931096 | Direct |
| 2013-11-14 | Common Stock | P | 999 | $1898.1 | Acquired | 932095 | Direct |
Footnotes
F1: The total 57,292 shares were acquired on March 25, 2013, of which 50,000 shares were purchased at a cost basis of $2.00 per share and 7,292 shares were acquired for the settlement of an existing debt valued at $14,583.22.
F2: The 4,878 shares were purchased at a cost basis of $1.63 per share.
F3: The 99 shares were purchased at a cost basis of $1.90 per share.
F4: P/J
More from VOLITIONRX LTD
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 13
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Apr 1